Amotosalen and ultraviolet‐A treated platelets and plasma are safe and efficacious in active hemorrhage

R. Benjamin,K. Carter,L. Corash
DOI: https://doi.org/10.1111/trf.13786
2016-10-01
Transfusion
Abstract:1. Newman PJ, Aster R, Boylan B. Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders. J Thromb Haemost 2007;5(suppl 1):305-9. 2. Bougie DW, Nayak D, Boylan B, et al. Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia. Blood 2010;116:3033-8. 3. Fuhrmann J, Jouni R, Alex J, et al. Assessment of human platelet survival in the NOD/SCID mouse model: technical considerations. Transfusion 2016;56:1370-6. 4. Knight DM, Wagner C, Jordan R, et al. The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions. Mol Immunol 1995;32:1271-81. 5. Overdijk MB, Verploegen S, Ortiz Buijsse A, et al. Crosstalk between human IgG isotypes and murine effector cells. J Immunol 2012;189:3430-8.
What problem does this paper attempt to address?